CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 45 enrolled
Drug / intervention
High Sulforaphane Extract (Broccoli Sprout Extract) +1 moredrug
Likely dose
Microcrystalline Cellulose NF (placebo) 250 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00946309
NCT00946309Phase 2Completed
CompareCT.gov

In Vivo Effects of Sulforaphane Supplementation on Normal Human Prostate

Fred Hutchinson Cancer Center·interventional·Posted Jul 27, 2009·Updated Nov 15, 2016

In Brief

A Phase 2 clinical trial evaluating High Sulforaphane Extract (Broccoli Sprout Extract) and Microcrystalline Cellulose NF (placebo) for Prostate Cancer. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The investigators proposed to identify the biological effects of a high-sulforaphane broccoli sprout extract in normal prostate tissue. The investigators hypothesize that consumption of high-sulforaphane broccoli sprout extract every other day will inhibit growth of prostate cancer cells.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsVA Puget Sound Health Care System, Seattle Institute for Biomedical and Clinical Research, Johns Hopkins University, University of Washington, Cedars-Sinai Medical Center

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 27, 2009
Enrollment StartJul 1, 2010
Primary CompletionMay 1, 2014
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.9 years ago

Interventions

High Sulforaphane Extract (Broccoli Sprout Extract)drug

100 umol sulforaphane, every other day for 5 weeks

Microcrystalline Cellulose NF (placebo)drug

250 mg every other day for 6 weeks